 Committee
Introduction
Benefits
Meetings
| Committee |
|
Chairperson
(contact person) |
Ursula Theuretzbacher
Center for Anti-Infective Agents (CEFAIA)
Eckpergasse 13
A-1180 Vienna
Austria
E-mail: utheuretzbacher@cefaia.com |
| Co-chair |
Jean Claude Pechère
19 Krieg
CH-1208 Geneva
Switzerland
E-mail: jcpechere@yahoo.com |
Introduction
Antibiotic resistance is recognized worldwide as a major
problem in the management of infectious disease, both in
hospital settings and the community. While most major pharmaceutical
companies have either abandoned or reduced efforts in antibiotic
research and development in favour of areas such as chronic
illness, smaller companies face many challenges but continue
to pursue a wide variety of approaches.
The pharmaceutical industry, academic and government researchers
are calling for new and increased collaborations among pharmaceutical
companies, academic researchers and regulatory agencies to
strengthen the research and drug development processes. Improved
information and active networks are linking resources and
knowledge.
We are providing an international platform for promoting
and encouraging the effective exchange of information about
research and development activities in the anti-infective
field. Our platform supports information flows between academia,
clinicians and industry researchers and raises awareness
on all sides for the needs of the medical community as well
as the problems related to developing these drugs.
Benefits
Academia: obtaining information about activities in their
field of interest in other countries and settings, facilitate
collaboration with industry.
Clinicians: debating the need for and obtaining information
about potential availability of future anti-infective and
cancer drugs.
Industry: sharing information about “in-out” licensing
and collaboration opportunities and research activities in
their field, gaining visibility.
Meetings
The ISC Working Group on Antimicrobials of the Future has
(co-)organized the following meetings and symposia:
| March 2007 |
Symposium: “Reconciling the goals of antibiotic
policy and drug development” at the 25th ICC /
17th ECCMID, Munich, Germany |
| November 2007 |
DMS: "New targets, new drugs, new challenges." Istanbul,
Turkey |
| October 2007 |
SYMPOSIUM Future Strategies in Drug Development and Prescribing at the 2nd WORLD CONGRESS Devising Improved Methods for Identification and Treatment of Infectious Diseases. Boston, USA |
For further information on ISC meetings
go to:
ISC Future Meetings
ISC Past Meetings
Last edition:
août 7, 2007
|
2008
